Literature DB >> 26763886

Neurogenic plasticity of mesenchymal stem cell, an alluring cellular replacement for traumatic brain injury.

Soumya Pati, Sangu Muthuraju, Raisah Ab Hadi, Tee Jong Huat, Shailja Singh, Mirjana Maletic-Savatic, Jafri Malin Abdullah1, Hasnan Jaafar.   

Abstract

Traumatic brain injury (TBI) imposes horrendous neurophysiological alterations leading to most devastating forms of neuro-disability. Which includes impaired cognition, distorted locomotors activity and psychosomatic disability in both youths and adults. Emerging evidence from recent studies has identified mesenchymal stem cells (MSCs) as one of the promising category of stem cells having excellent neuroregenerative capability in TBI victims. Some of the clinical and animal studies reported that MSCs transplantation could cure neuronal damage as well as improve cognitive and locomotors behaviors in TBI. However, mechanism behind their broad spectrum neuroregenerative potential in TBI has not been reviewed yet. Therefore, in the present article, we present a comprehensive data on the important attributes of MSCs, such as neurotransdifferentiation, neuroprotection, axonal repair and plasticity, maintenance of blood-brain integrity, reduction of reactive oxygen species (ROS) and immunomodulation. We have reviewed in detail the crucial neurogenic capabilities of MSCs in vivo and provided consolidated knowledge regarding their cellular remodeling in TBI for future therapeutic implications.

Entities:  

Mesh:

Year:  2016        PMID: 26763886     DOI: 10.2174/1574888x10666151019120050

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  5 in total

1.  Diffuse white matter response in trauma-injured brain to bone marrow stromal cell treatment detected by diffusional kurtosis imaging.

Authors:  Lian Li; Michael Chopp; Guangliang Ding; Esmaeil Davoodi-Bojd; Qingjiang Li; Asim Mahmood; Ye Xiong; Quan Jiang
Journal:  Brain Res       Date:  2019-04-19       Impact factor: 3.252

2.  Conditioned Medium of Bone Marrow-Derived Mesenchymal Stromal Cells as a Therapeutic Approach to Neuropathic Pain: A Preclinical Evaluation.

Authors:  Kelly Barbosa Gama; Dourivaldo Silva Santos; Afrânio Ferreira Evangelista; Daniela Nascimento Silva; Adriano Costa de Alcântara; Ricardo Ribeiro Dos Santos; Milena Botelho Pereira Soares; Cristiane Flora Villarreal
Journal:  Stem Cells Int       Date:  2018-01-30       Impact factor: 5.443

Review 3.  Usage of Human Mesenchymal Stem Cells in Cell-based Therapy: Advantages and Disadvantages.

Authors:  Hee Jung Kim; Jeong-Soo Park
Journal:  Dev Reprod       Date:  2017-03-31

4.  Bone marrow stromal cells promote neuromotor functional recovery, via upregulation of neurotrophic factors and synapse proteins following traumatic brain injury in rats.

Authors:  Yan Feng; Yaru Ju; Jianzhong Cui; Liqun Wang
Journal:  Mol Med Rep       Date:  2017-05-25       Impact factor: 2.952

5.  Isolation and Characterization of Neural Progenitor Cells From Bone Marrow in Cell Replacement Therapy of Brain Injury.

Authors:  Wen-Fang Bai; Yuling Zhang; Weicheng Xu; Weikun Li; Meihui Li; Fengying Yuan; Xun Luo; Mingsheng Zhang
Journal:  Front Cell Neurosci       Date:  2020-03-12       Impact factor: 5.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.